Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by CytochromePon Oct 20, 2017 10:23am

157 Views

Post# 26836277

RE:Clarus projections

You made the bashers vanish GoBlue, I never knew you were a magician.

GoBlue2016 wrote:
“Analysts at Clarus Securities upped their FY2018 earnings estimates for Aphria in a report released on Monday. Clarus Securities analyst N. Atkinson now anticipates that the company will post earnings of $0.15 per share for the year, up from their previous forecast of $0.06. Clarus Securities also issued estimates for Aphria’s FY2019 earnings at $0.42 EPS.”

At 150 million shares approx after bought deal that is

F2018 Net Income $22.5 million

F2019 Net Income $63 million

F2018 has sales from only PI and PII. AS PIII first harvest for sale is their last month of F2018.

F2019 only has 4 months of sales from PIV.

GoBlue